Board Meetings for BALPHARMA
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| BALPHARMA | Bal Pharma Limited | 09 Sept 2024 | BAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 09-Sep-2024 to consider and approve ESOP/Other business. | Board Meeting Intimation | |
| BALPHARMA | Bal Pharma Limited | 12 Aug 2024 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters | |
| BALPHARMA | Bal Pharma Limited | 12 Aug 2024 | BAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and ESOP/Other business. | Board Meeting Intimation | |
| BALPHARMA | Bal Pharma Limited | 28 May 2024 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters | |
| BALPHARMA | Bal Pharma Limited | 28 May 2024 | BAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend/Other business. | Board Meeting Intimation | |
| BALPHARMA | Bal Pharma Limited | 12 Feb 2024 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and to consider investing additional capital in expanding its manufacturing presence , through a green field project. | |
| BALPHARMA | Bal Pharma Limited | 12 Feb 2024 | BAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2023 and Other business. | Board Meeting Intimation | |
| BALPHARMA | Bal Pharma Limited | 08 Nov 2023 | BAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 08-Nov-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2023 and ESOP/Other business. | Board Meeting Intimation | |
| BALPHARMA | Bal Pharma Limited | 08 Nov 2023 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters | |
| BALPHARMA | Bal Pharma Limited | 11 Aug 2023 | Financial Results/Other business matters | 1.To consider and approve the Un-audited financial results (Standalone and Consolidated) for the period ended Jun 30, 2023 .2. To Convene 36th Annual General Meeting of the Company.3. To decide on the Book Closure dates.4. Other AGM related matters. | |
| BALPHARMA | Bal Pharma Limited | 11 Aug 2023 | BAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 11-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2023 and Other business. | Board Meeting Intimation | |
| BALPHARMA | Bal Pharma Limited | 29 May 2023 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2023, dividend and other business matters | |
| BALPHARMA | Bal Pharma Limited | 29 May 2023 | BAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend/Other business. | Board Meeting Intimation | |
| BALPHARMA | Bal Pharma Limited | 06 Feb 2023 | Financial Results | To consider and approve the financial results for the period ended December 31, 2022 | |
| BALPHARMA | Bal Pharma Limited | 14 Nov 2022 | Financial results/Other business matters | Bal Pharma Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2022 to consider financial statements for the period ended September 2022 and Other business matters |